Skip to content
Selenium sulfide
Exsel, Selsun (selenium sulfide) is a small molecule pharmaceutical. Selenium sulfide was first approved as Selsun on 1982-01-01. It is used to treat dandruff, deficiency diseases, scalp dermatoses, seborrheic dermatitis, and tinea capitis amongst others in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
skin and connective tissue diseasesD017437
nutritional and metabolic diseasesD009750
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Selenium sulfide
Tradename
Company
Number
Date
Products
SELSUNSanofiN-007936 DISCN1982-01-01
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
exsel sportOTC monograph not final2013-08-06
head and shoulders 2in1 clinical strength dandruff defense advanced oil controlOTC monograph final2023-06-13
selsun blue itchy dry scalpOTC monograph final2022-10-27
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
dandruff—D063807L21.0
deficiency diseasesEFO_1001067D003677E63
scalp dermatoses—D012536—
seborrheic dermatitis—D012628L21
tinea capitis—D014006B35.0
tinea versicolorEFO_0007439D014010B36.0
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
D: Dermatologicals
— D01: Antifungals for dermatological use
— D01A: Antifungals for topical use
— D01AE: Other antifungals for topical use in atc
— D01AE13: Selenium sulfide
HCPCS
No data
Clinical
Clinical Trials
11 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ContraceptionD003267521——8
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients—21———3
Ovulation inhibitionD034445—1———1
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameSELENIUM SULFIDE
INN—
Description
Selenium sulfide is a sulfide salt.
Classification
Small molecule
Drug classquaternary ammonium derivatives
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
S=[Se]=S
Identifiers
PDB—
CAS-ID7488-56-4
RxCUI36345
ChEMBL IDCHEMBL1200680
ChEBI ID—
PubChem CID24087
DrugBankDB00971
UNII ID—
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 373 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
138 adverse events reported
View more details